A Study of Bortezomib Combined With CHEP in Peripheral T Cell Lymphoma
Condition: Peripheral T Cell Lymphoma Interventions: Drug: Bortezomib; Drug: Etoposide; Drug: Cyclophosphamide; Drug: Pharmorubicin; Drug: Prednisone Sponsor: Zhejiang Cancer Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Hospitals | Lymphoma | Prednisone | Research | Study | T-cell Lymphoma | Velcade